- Home
- IMTX vs PRAA Comparison
IMTX vs PRAA Comparison
Compare IMTX & PRAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMTX
- PRAA
- Stock Information
- Founded
- IMTX N/A
- PRAA 1996
- Country
- IMTX Germany
- PRAA United States
- Employees
- IMTX N/A
- PRAA N/A
- Industry
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- PRAA Finance: Consumer Services
- Sector
- IMTX Health Care
- PRAA Finance
- Exchange
- IMTX Nasdaq
- PRAA Nasdaq
- Market Cap
- IMTX 954.2M
- PRAA 834.7M
- IPO Year
- IMTX N/A
- PRAA N/A
- Fundamental
- Price
- IMTX $5.35
- PRAA $21.31
- Analyst Decision
- IMTX Strong Buy
- PRAA Strong Buy
- Analyst Count
- IMTX 4
- PRAA 2
- Target Price
- IMTX $16.67
- PRAA $32.00
- AVG Volume (30 Days)
- IMTX 988.8K
- PRAA 302.2K
- Earning Date
- IMTX 11-18-2024
- PRAA 02-13-2025
- Dividend Yield
- IMTX N/A
- PRAA N/A
- EPS Growth
- IMTX N/A
- PRAA N/A
- EPS
- IMTX N/A
- PRAA 1.10
- Revenue
- IMTX $128,824,447.00
- PRAA $1,042,710,000.00
- Revenue This Year
- IMTX $116.22
- PRAA $39.43
- Revenue Next Year
- IMTX N/A
- PRAA $6.61
- P/E Ratio
- IMTX N/A
- PRAA $19.33
- Revenue Growth
- IMTX 52.53
- PRAA 29.69
- 52 Week Low
- IMTX $5.28
- PRAA $18.64
- 52 Week High
- IMTX $13.77
- PRAA $31.43
- Technical
- Relative Strength Index (RSI)
- IMTX 21.22
- PRAA 55.63
- Support Level
- IMTX $7.00
- PRAA $19.17
- Resistance Level
- IMTX $7.42
- PRAA $21.01
- Average True Range (ATR)
- IMTX 0.41
- PRAA 0.68
- MACD
- IMTX -0.14
- PRAA 0.12
- Stochastic Oscillator
- IMTX 2.90
- PRAA 87.75
About IMTX Immatics N.V.
Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.
About PRAA PRA Group Inc.
PRA Group Inc is a leader in acquiring and collecting nonperforming loans. The company returns capital to banks and other creditors to help expand financial services for consumers in the Americas, Europe, and Australia. It is also engaged in providing fee-based services on class action claims recoveries in the United States. The company's portfolio segments include; Core, which is engaged in purchasing and collecting nonperforming loans, which the originators have not chosen not to pursue, and the Insolvency segment which is engaged in purchasing and collecting nonperforming loans where the customer is involved in a bankruptcy proceeding.